MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-systemische-therapie-substanzen-2021 | Version: 2027.0.0-ballot.1 | |||
| Active as of 2026-09-15 | Computable Name: MII_VS_Onko_Systemische_Therapie_Substanzen_2021 | |||
ATC-Codes für Substanzen der systemischen Therapie, validiert gegen ATC-DE Version 2021. Für historische Datenvalidierung.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Profiles: Shareable ValueSet, CRMI Shareable ValueSet, CRMI Publishable ValueSet, CRMI Computable ValueSet
http://fhir.de/CodeSystem/bfarm/atc version 📍2021| Code | Display | MII CM Onko ATC Code Changes 2021 to 2022 |
| L02BX01 | Abarelix | |
| L04AA24 | Abatacept | |
| L01EF03 | Abemaciclib | |
| L04AA22 | Abetimus | |
| L02BX03 | Abirateron | |
| L01EL02 | Acalabrutinib | |
| L01DB04 | Aclarubicin | |
| L04AB04 | Adalimumab | |
| L01EB03 | Afatinib | |
| L04AB03 | Afelimomab | |
| L01XX44 | Aflibercept | |
| L03AC01 | Aldesleukin | |
| L01ED03 | Alectinib | |
| L04AA15 | Alefacept | |
| L04AA34 | Alemtuzumab | |
| M05BA04 | Alendronsäure | |
| L01XF02 | Alitretinoin | |
| L01EM03 | Alpelisib | |
| L01XX03 | Altretamin | |
| V03AM01 | Amilomer | |
| L02BG01 | Aminoglutethimid | |
| L01XD04 | Aminolevulinsäure | |
| L01DB10 | Amrubicin | |
| L01XX01 | Amsacrin | |
| L01XX35 | Anagrelid | |
| L04AC03 | Anakinra | |
| L02BG03 | Anastrozol | |
| L04AA04 | Antithymozytäres Immunglobulin (Kaninchen) | |
| L02BB05 | Apalutamid | |
| L01XX27 | Arsentrioxid | |
| P01BE03 | Artesunat | |
| L01XX02 | Asparaginase | |
| L01XC32 | Atezolizumab | ~L01FF05(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01EX18 | Avapritinib | |
| L01XC31 | Avelumab | ~L01FF04(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01XX70 | Axicabtagen Ciloleucel | |
| L01EK01 | Axitinib | |
| L01BC07 | Azacitidin | |
| L04AX01 | Azathioprin | |
| L04AC02 | Basiliximab | |
| L03AX03 | BCG-Impfstoff | |
| L04AA28 | Belatacept | |
| L04AA26 | Belimumab | |
| L01XH04 | Belinostat | |
| L01AA09 | Bendamustin | |
| L01XC07 | Bevacizumab | ~L01FG01(Reklassifizierung zu VEGF-/VEGFR-Inhibitoren) |
| L01XF03 | Bexaroten | |
| L02BB03 | Bicalutamid | |
| L01EE03 | Binimetinib | |
| L01DC01 | Bleomycin | |
| L01XC19 | Blinatumomab | ~L01FX07(Reklassifizierung zu andere monoklonale Antikörper) |
| L01XG01 | Bortezomib | |
| L01EA04 | Bosutinib | |
| L01XC12 | Brentuximab vedotin | ~L01FX05(Reklassifizierung zu andere monoklonale Antikörper) |
| L04AC09 | Briakinumab | |
| L01ED04 | Brigatinib | |
| N04BC01 | Bromocriptin | |
| L02AE01 | Buserelin | |
| L01AB01 | Busulfan | |
| L01CD04 | Cabazitaxel | |
| N04BC06 | Cabergolin | |
| L01EX07 | Cabozantinib | |
| V03AF04 | Calciumlevofolinat | |
| L04AC08 | Canakinumab | |
| L01BC06 | Capecitabin | |
| L01EX17 | Capmatinib | |
| L01XA02 | Carboplatin | |
| L01AC03 | Carboquon | |
| L01XG02 | Carfilzomib | |
| L01BC04 | Carmofur | |
| L01AD01 | Carmustin | |
| L01ED02 | Ceritinib | |
| L04AB05 | Certolizumab pegol | |
| H01CC02 | Cetrorelix | |
| L01XC06 | Cetuximab | ~L01FE01(Reklassifizierung zu EGFR-Inhibitoren) |
| L01AA02 | Chlorambucil | |
| G03DB06 | Chlormadinon | |
| L01AA05 | Chlormethin | |
| L04AD01 | Ciclosporin | |
| L01XA01 | Cisplatin | |
| L01BB04 | Cladribin | |
| M05BA02 | Clodronsäure | |
| L01BB06 | Clofarabin | |
| L01EE02 | Cobimetinib | |
| L01EM02 | Copanlisib | |
| L01ED01 | Crizotinib | |
| L01AA01 | Cyclophosphamid | |
| G03HA01 | Cyproteron | |
| L01BC01 | Cytarabin | |
| L01XY01 | Cytarabin und Daunorubicin | |
| L01EC02 | Dabrafenib | |
| L01AX04 | Dacarbazin | |
| L04AC01 | Daclizumab | |
| L01EB07 | Dacomitinib | |
| L01DA01 | Dactinomycin | |
| L01XC24 | Daratumumab | ~L01FC01(Reklassifizierung zu CD38-Inhibitoren) |
| B03XA02 | Darbepoetin alfa | |
| L02BB06 | Darolutamid | |
| L01EA02 | Dasatinib | |
| L01DB02 | Daunorubicin | |
| L01BC08 | Decitabin | |
| L02BX02 | Degarelix | |
| L01CC01 | Demecolcin | |
| L01XX29 | Denileukindiftitox | |
| M05BX04 | Denosumab | |
| H02AB02 | Dexamethason | |
| L01CD02 | Docetaxel | |
| L01DB01 | Doxorubicin | |
| L01XC28 | Durvalumab | ~L01FF03(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| G04CB02 | Dutasterid | |
| L01EM04 | Duvelisib | |
| L04AA25 | Eculizumab | |
| L04AA21 | Efalizumab | |
| L01XD06 | Efaproxiral | |
| B02BX05 | Eltrombopag | |
| L01XX59 | Enasidenib | |
| L01EC03 | Encorafenib | |
| L01EX14 | Entrectinib | |
| L02BB04 | Enzalutamid | |
| L01DB03 | Epirubicin | |
| L01XX41 | Eribulin | |
| L01EB02 | Erlotinib | |
| B03XA01 | Erythropoietin | |
| L01XX11 | Estramustin | |
| L04AB01 | Etanercept | |
| M05BA01 | Etidronsäure | |
| L01AG01 | Etoglucid | |
| L01CB01 | Etoposid | |
| L01EG02 | Everolimus | |
| L02BG06 | Exemestan | |
| L01EJ02 | Fedratinib | |
| L03AA02 | Filgrastim | |
| G04CB01 | Finasterid | |
| L04AA27 | Fingolimod | |
| L01BC09 | Floxuridin | |
| L01BB05 | Fludarabin | |
| L01BC02 | Fluorouracil | |
| L01BC52 | Fluorouracil, Kombinationen | |
| L02BB01 | Flutamid | |
| V03AF03 | Calciumfolinat | |
| L02BG02 | Formestan | |
| L02AA04 | Fosfestrol | |
| B02BX09 | Fostamatinib | |
| L01AD05 | Fotemustin | |
| L02BA03 | Fulvestrant | |
| L01EB01 | Gefitinib | |
| L01BC05 | Gemcitabin | |
| L02AB03 | Gestonoron | |
| L01EX13 | Gilteritinib | |
| L01XJ03 | Glasdegib | |
| L04AB06 | Golimumab | |
| H01CA01 | Gonadorelin | |
| L02AE03 | Goserelin | |
| L04AA19 | Gusperimus | |
| L03AX14 | Histamindihydrochlorid | |
| L02AE05 | Histrelin | |
| L01XX05 | Hydroxycarbamid | |
| M05BA06 | Ibandronsäure | |
| V10XX02 | (90Y)Ibritumomabtiuxetan | |
| L01EL01 | Ibrutinib | |
| L01DB06 | Idarubicin | |
| L01EM01 | Idelalisib | |
| L01AA06 | Ifosfamid | |
| L01EA01 | Imatinib | |
| D06BB10 | Imiquimod | |
| L04AB02 | Infliximab | |
| D06BX02 | Ingenolmebutat | |
| L01XC26 | Inotuzumab ozogamicin | ~L01FB01(Reklassifizierung zu CD22-Inhibitoren) |
| L03AB01 | Interferon alfa, natürlich | |
| L03AB04 | Interferon alfa-2a | |
| L03AB05 | Interferon alfa-2b | |
| L03AB18 | Interferon gamma-1b | |
| L01XC11 | Ipilimumab | ~L01FX04(Reklassifizierung zu andere monoklonale Antikörper) |
| L01CE02 | Irinotecan | |
| L01XX62 | Ivosidenib | |
| L01DC04 | Ixabepilon | |
| L01XG03 | Ixazomib | |
| H02CA03 | Ketoconazol | |
| H01CB03 | Lanreotid | |
| L01EH01 | Lapatinib | |
| L01EX12 | Larotrectinib | |
| L04AA13 | Leflunomid | |
| L04AX04 | Lenalidomid | |
| L03AA10 | Lenograstim | |
| L01EX08 | Lenvatinib | |
| L02BG04 | Letrozol | |
| L02AE02 | Leuprorelin | |
| L03AA14 | Lipegfilgrastim | |
| L01AD02 | Lomustin | |
| L01XX07 | Lonidamin | |
| L01ED05 | Lorlatinib | |
| B03XA06 | Luspatercept | |
| G03DC03 | Lynestrenol | |
| L01AB03 | Mannosulfan | |
| J05AX09 | Maraviroc | |
| L01XX10 | Masoprocol | |
| L02AB02 | Medroxyprogesteron | |
| L02AB01 | Megestrol | |
| L01AA03 | Melphalan | |
| R03DX09 | Mepolizumab | |
| L01BB02 | Mercaptopurin | |
| V03AF01 | Mesna | |
| N07BC02 | Methadon | |
| L01BA01 | Methotrexat | |
| L01XD10 | Methoxsalen | |
| B03XA03 | Methoxy-Polyethylenglycol-Epoetin beta | |
| L01XD03 | Methylaminolevulinat | |
| H02AB04 | Methylprednisolon | |
| L01EX10 | Midostaurin | |
| L03AX15 | Mifamurtid | |
| L01XX09 | Miltefosin | |
| L01CH01 | Mistelkraut | |
| L01CP01 | Mistelkraut | |
| L01AX01 | Mitobronitol | |
| L01XX16 | Mitoguazon | |
| L01DC03 | Mitomycin | |
| L01XX23 | Mitotan | |
| L01DB07 | Mitoxantron | |
| L03AA03 | Molgramostim | |
| L04AA02 | Muromonab-CD3 | |
| L04AA06 | Mycophenolsäure | |
| L04AA23 | Natalizumab | |
| V03AF10 | Natriumlevofolinat | |
| L01BB07 | Nelarabin | |
| L01EH02 | Neratinib | |
| L01EA03 | Nilotinib | |
| L02BB02 | Nilutamid | |
| L01AD06 | Nimustin | |
| L01EX09 | Nintedanib | |
| L01XK02 | Niraparib | |
| L01XC17 | Nivolumab | ~L01FF01(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01XC15 | Obinutuzumab | ~L01FA03(Reklassifizierung zu CD20-Inhibitoren) |
| L01XX36 | Oblimersen | |
| H01CB02 | Octreotid | |
| L01XK01 | Olaparib | |
| L01XC27 | Olaratumab | ~L01FX10(Reklassifizierung zu andere monoklonale Antikörper) |
| L01XX40 | Omacetaxinmepesuccinat | |
| L03AC02 | Oprelvekin | |
| L01EB04 | Osimertinib | |
| L01XA03 | Oxaliplatin | |
| L01CD01 | Paclitaxel | |
| L01CD03 | Paclitaxelpoliglumex | |
| L01EF01 | Palbociclib | |
| V03AF08 | Palifermin | |
| M05BA03 | Pamidronsäure | |
| L01XC08 | Panitumumab | ~L01FE02(Reklassifizierung zu EGFR-Inhibitoren) |
| L01XH03 | Panobinostat | |
| L01EX03 | Pazopanib | |
| L01XX24 | Pegaspargase | |
| L03AA13 | Pegfilgrastim | |
| L03AB11 | Peginterferon alfa-2a | |
| L03AB10 | Peginterferon alfa-2b | |
| L01XC18 | Pembrolizumab | ~L01FF02(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01BA04 | Pemetrexed | |
| L01XX08 | Pentostatin | |
| L01XC13 | Pertuzumab | ~L01FD02(Reklassifizierung zu HER2-Inhibitoren) |
| L01AX02 | Pipobroman | |
| L01DB08 | Pirarubicin | |
| L01DB11 | Pixantron | |
| V03AX10 | Placebo | |
| L03AX16 | Plerixafor | |
| L01DC02 | Plicamycin | |
| L03AX08 | Poly ICLC | |
| L02AA02 | Polyestradiolphosphat | |
| L01XA05 | Polyplatillen | |
| L04AX06 | Pomalidomid | |
| L01EA05 | Ponatinib | |
| L01XD01 | Porfimer natrium | |
| L01BA05 | Pralatrexat | |
| D07AC18 | Prednicarbat | |
| L01AA08 | Prednimustin | |
| H02AB06 | Prednisolon | |
| H02AB07 | Prednison | |
| L01XB01 | Procarbazin | |
| D05AD | Psoralene zur topischen Anwendung | |
| D05BA | Psoralene zur systemischen Anwendung | |
| L01EX11 | Quizartinib | |
| G03XC01 | Raloxifen | |
| L01BA03 | Raltitrexed | |
| L01XC21 | Ramucirumab | ~L01FG02(Reklassifizierung zu VEGF-/VEGFR-Inhibitoren) |
| L01AD07 | Ranimustin | |
| L01EX05 | Regorafenib | |
| L01EF02 | Ribociclib | |
| L04AC04 | Rilonacept | |
| L01EX19 | Ripretinib | |
| M05BA07 | Risedronsäure | |
| L01XC02 | Rituximab | ~L01FA01(Reklassifizierung zu CD20-Inhibitoren) |
| L01XH02 | Romidepsin | |
| B02BX04 | Romiplostim | |
| L03AB15 | Ropeginterferon alfa-2b | |
| L01XK03 | Rucaparib | |
| L01EJ01 | Ruxolitinib | |
| L01XA04 | Satraplatin | |
| L01XX66 | Selinexor | |
| L01EE04 | Selumetinib | |
| L01AD03 | Semustin | |
| L04AC11 | Siltuximab | |
| L04AA10 | Sirolimus | |
| H01CB01 | Somatostatin | |
| L01XJ02 | Sonidegib | |
| L01EX02 | Sorafenib | |
| L01AD04 | Streptozocin | |
| L01EX01 | Sunitinib | |
| L04AD02 | Tacrolimus | |
| L01XX67 | Tagraxofusp | |
| L01XK04 | Talazoparib | |
| L01XX51 | Talimogen laherparepvec | |
| L02BA01 | Tamoxifen | |
| L03AX11 | Tasonermin | |
| L01BC53 | Tegafur, Kombinationen | |
| L01BC63 | Tegafur und Uracil | |
| L01BC73 | Tegafur, Gimeracil und Oteracil | |
| L01XD05 | Temoporfin | |
| L01AX03 | Temozolomid | |
| L01EG01 | Temsirolimus | |
| L01CB02 | Teniposid | |
| L01EX21 | Tepotinib | |
| L04AX02 | Thalidomid | |
| L01AC01 | Thiotepa | |
| L01XX18 | Tiazofurin | |
| M05BA05 | Tiludronsäure | |
| L01BB03 | Tioguanin | |
| L01XX71 | Tisagenlecleucel | |
| L01EK03 | Tivozanib | |
| L04AC07 | Tocilizumab | |
| L01CE01 | Topotecan | |
| L02BA02 | Toremifen | |
| V10XA53 | Tositumomab/(131I)Iodtositumomab | |
| L01CX01 | Trabectedin | |
| L01EE01 | Trametinib | |
| L01XC03 | Trastuzumab | ~L01FD01(Reklassifizierung zu HER2-Inhibitoren) |
| L01XC14 | Trastuzumab emtansin | ~L01FD03(Reklassifizierung zu HER2-Inhibitoren) |
| L01AB02 | Treosulfan | |
| L01XF01 | Tretinoin | |
| L01AC02 | Triaziquon | |
| L01BC59 | Trifluridin, Kombinationen | |
| L02AE04 | Triptorelin | |
| L01AA07 | Trofosfamid | |
| L01EH03 | Tucatinib | |
| L01AD08 | Uramustin | |
| N03AG01 | Valproinsäure | |
| L01DB09 | Valrubicin | |
| L01EX04 | Vandetanib | |
| L01XK05 | Veliparib | |
| L01EC01 | Vemurafenib | |
| L01XX52 | Venetoclax | |
| L01CA01 | Vinblastin | |
| L01CA02 | Vincristin | |
| L01CA03 | Vindesin | |
| L01CA05 | Vinflunin | |
| L01CA04 | Vinorelbin | |
| L01XJ01 | Vismodegib | |
| L04AD03 | Voclosporin | |
| L01XH01 | Vorinostat | |
| L02BG05 | Vorozol | |
| L01XX53 | Vosaroxin | |
| L01EL03 | Zanubrutinib | |
| M05BA08 | Zoledronsäure | |
| L01DB05 | Zorubicin |
Expansion from 127.0.0.1 based on codesystem atc version 2021
This value set contains 359 concepts
| System | Code | Display (en) | MII CM Onko ATC Code Changes 2021 to 2022 | JSON | XML |
http://fhir.de/CodeSystem/bfarm/atc | L02BX01 | Abarelix | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA24 | Abatacept | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EF03 | Abemaciclib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA22 | Abetimus | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BX03 | Abirateron | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EL02 | Acalabrutinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DB04 | Aclarubicin | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AB04 | Adalimumab | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EB03 | Afatinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AB03 | Afelimomab | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX44 | Aflibercept | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AC01 | Aldesleukin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01ED03 | Alectinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA15 | Alefacept | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA34 | Alemtuzumab | |||
http://fhir.de/CodeSystem/bfarm/atc | M05BA04 | Alendronsäure | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XF02 | Alitretinoin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EM03 | Alpelisib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX03 | Altretamin | |||
http://fhir.de/CodeSystem/bfarm/atc | V03AM01 | Amilomer | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BG01 | Aminoglutethimid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XD04 | Aminolevulinsäure | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DB10 | Amrubicin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX01 | Amsacrin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX35 | Anagrelid | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AC03 | Anakinra | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BG03 | Anastrozol | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA04 | Antithymozytäres Immunglobulin (Kaninchen) | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BB05 | Apalutamid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX27 | Arsentrioxid | |||
http://fhir.de/CodeSystem/bfarm/atc | P01BE03 | Artesunat | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX02 | Asparaginase | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC32 | Atezolizumab | ~L01FF05(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01EX18 | Avapritinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC31 | Avelumab | ~L01FF04(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01XX70 | Axicabtagen Ciloleucel | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EK01 | Axitinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC07 | Azacitidin | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AX01 | Azathioprin | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AC02 | Basiliximab | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AX03 | BCG-Impfstoff | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA28 | Belatacept | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA26 | Belimumab | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XH04 | Belinostat | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AA09 | Bendamustin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC07 | Bevacizumab | ~L01FG01(Reklassifizierung zu VEGF-/VEGFR-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01XF03 | Bexaroten | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BB03 | Bicalutamid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EE03 | Binimetinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DC01 | Bleomycin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC19 | Blinatumomab | ~L01FX07(Reklassifizierung zu andere monoklonale Antikörper) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01XG01 | Bortezomib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EA04 | Bosutinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC12 | Brentuximab vedotin | ~L01FX05(Reklassifizierung zu andere monoklonale Antikörper) | ||
http://fhir.de/CodeSystem/bfarm/atc | L04AC09 | Briakinumab | |||
http://fhir.de/CodeSystem/bfarm/atc | L01ED04 | Brigatinib | |||
http://fhir.de/CodeSystem/bfarm/atc | N04BC01 | Bromocriptin | |||
http://fhir.de/CodeSystem/bfarm/atc | L02AE01 | Buserelin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AB01 | Busulfan | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CD04 | Cabazitaxel | |||
http://fhir.de/CodeSystem/bfarm/atc | N04BC06 | Cabergolin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX07 | Cabozantinib | |||
http://fhir.de/CodeSystem/bfarm/atc | V03AF04 | Calciumlevofolinat | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AC08 | Canakinumab | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC06 | Capecitabin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX17 | Capmatinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XA02 | Carboplatin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AC03 | Carboquon | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XG02 | Carfilzomib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC04 | Carmofur | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AD01 | Carmustin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01ED02 | Ceritinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AB05 | Certolizumab pegol | |||
http://fhir.de/CodeSystem/bfarm/atc | H01CC02 | Cetrorelix | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC06 | Cetuximab | ~L01FE01(Reklassifizierung zu EGFR-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01AA02 | Chlorambucil | |||
http://fhir.de/CodeSystem/bfarm/atc | G03DB06 | Chlormadinon | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AA05 | Chlormethin | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AD01 | Ciclosporin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XA01 | Cisplatin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BB04 | Cladribin | |||
http://fhir.de/CodeSystem/bfarm/atc | M05BA02 | Clodronsäure | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BB06 | Clofarabin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EE02 | Cobimetinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EM02 | Copanlisib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01ED01 | Crizotinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AA01 | Cyclophosphamid | |||
http://fhir.de/CodeSystem/bfarm/atc | G03HA01 | Cyproteron | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC01 | Cytarabin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XY01 | Cytarabin und Daunorubicin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EC02 | Dabrafenib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AX04 | Dacarbazin | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AC01 | Daclizumab | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EB07 | Dacomitinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DA01 | Dactinomycin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC24 | Daratumumab | ~L01FC01(Reklassifizierung zu CD38-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | B03XA02 | Darbepoetin alfa | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BB06 | Darolutamid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EA02 | Dasatinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DB02 | Daunorubicin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC08 | Decitabin | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BX02 | Degarelix | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CC01 | Demecolcin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX29 | Denileukindiftitox | |||
http://fhir.de/CodeSystem/bfarm/atc | M05BX04 | Denosumab | |||
http://fhir.de/CodeSystem/bfarm/atc | H02AB02 | Dexamethason | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CD02 | Docetaxel | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DB01 | Doxorubicin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC28 | Durvalumab | ~L01FF03(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | G04CB02 | Dutasterid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EM04 | Duvelisib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA25 | Eculizumab | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA21 | Efalizumab | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XD06 | Efaproxiral | |||
http://fhir.de/CodeSystem/bfarm/atc | B02BX05 | Eltrombopag | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX59 | Enasidenib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EC03 | Encorafenib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX14 | Entrectinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BB04 | Enzalutamid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DB03 | Epirubicin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX41 | Eribulin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EB02 | Erlotinib | |||
http://fhir.de/CodeSystem/bfarm/atc | B03XA01 | Erythropoietin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX11 | Estramustin | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AB01 | Etanercept | |||
http://fhir.de/CodeSystem/bfarm/atc | M05BA01 | Etidronsäure | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AG01 | Etoglucid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CB01 | Etoposid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EG02 | Everolimus | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BG06 | Exemestan | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EJ02 | Fedratinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AA02 | Filgrastim | |||
http://fhir.de/CodeSystem/bfarm/atc | G04CB01 | Finasterid | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA27 | Fingolimod | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC09 | Floxuridin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BB05 | Fludarabin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC02 | Fluorouracil | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC52 | Fluorouracil, Kombinationen | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BB01 | Flutamid | |||
http://fhir.de/CodeSystem/bfarm/atc | V03AF03 | Calciumfolinat | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BG02 | Formestan | |||
http://fhir.de/CodeSystem/bfarm/atc | L02AA04 | Fosfestrol | |||
http://fhir.de/CodeSystem/bfarm/atc | B02BX09 | Fostamatinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AD05 | Fotemustin | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BA03 | Fulvestrant | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EB01 | Gefitinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC05 | Gemcitabin | |||
http://fhir.de/CodeSystem/bfarm/atc | L02AB03 | Gestonoron | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX13 | Gilteritinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XJ03 | Glasdegib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AB06 | Golimumab | |||
http://fhir.de/CodeSystem/bfarm/atc | H01CA01 | Gonadorelin | |||
http://fhir.de/CodeSystem/bfarm/atc | L02AE03 | Goserelin | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA19 | Gusperimus | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AX14 | Histamindihydrochlorid | |||
http://fhir.de/CodeSystem/bfarm/atc | L02AE05 | Histrelin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX05 | Hydroxycarbamid | |||
http://fhir.de/CodeSystem/bfarm/atc | M05BA06 | Ibandronsäure | |||
http://fhir.de/CodeSystem/bfarm/atc | V10XX02 | (90Y)Ibritumomabtiuxetan | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EL01 | Ibrutinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DB06 | Idarubicin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EM01 | Idelalisib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AA06 | Ifosfamid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EA01 | Imatinib | |||
http://fhir.de/CodeSystem/bfarm/atc | D06BB10 | Imiquimod | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AB02 | Infliximab | |||
http://fhir.de/CodeSystem/bfarm/atc | D06BX02 | Ingenolmebutat | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC26 | Inotuzumab ozogamicin | ~L01FB01(Reklassifizierung zu CD22-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L03AB01 | Interferon alfa, natürlich | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AB04 | Interferon alfa-2a | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AB05 | Interferon alfa-2b | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AB18 | Interferon gamma-1b | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC11 | Ipilimumab | ~L01FX04(Reklassifizierung zu andere monoklonale Antikörper) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01CE02 | Irinotecan | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX62 | Ivosidenib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DC04 | Ixabepilon | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XG03 | Ixazomib | |||
http://fhir.de/CodeSystem/bfarm/atc | H02CA03 | Ketoconazol | |||
http://fhir.de/CodeSystem/bfarm/atc | H01CB03 | Lanreotid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EH01 | Lapatinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX12 | Larotrectinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA13 | Leflunomid | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AX04 | Lenalidomid | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AA10 | Lenograstim | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX08 | Lenvatinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BG04 | Letrozol | |||
http://fhir.de/CodeSystem/bfarm/atc | L02AE02 | Leuprorelin | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AA14 | Lipegfilgrastim | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AD02 | Lomustin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX07 | Lonidamin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01ED05 | Lorlatinib | |||
http://fhir.de/CodeSystem/bfarm/atc | B03XA06 | Luspatercept | |||
http://fhir.de/CodeSystem/bfarm/atc | G03DC03 | Lynestrenol | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AB03 | Mannosulfan | |||
http://fhir.de/CodeSystem/bfarm/atc | J05AX09 | Maraviroc | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX10 | Masoprocol | |||
http://fhir.de/CodeSystem/bfarm/atc | L02AB02 | Medroxyprogesteron | |||
http://fhir.de/CodeSystem/bfarm/atc | L02AB01 | Megestrol | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AA03 | Melphalan | |||
http://fhir.de/CodeSystem/bfarm/atc | R03DX09 | Mepolizumab | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BB02 | Mercaptopurin | |||
http://fhir.de/CodeSystem/bfarm/atc | V03AF01 | Mesna | |||
http://fhir.de/CodeSystem/bfarm/atc | N07BC02 | Methadon | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BA01 | Methotrexat | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XD10 | Methoxsalen | |||
http://fhir.de/CodeSystem/bfarm/atc | B03XA03 | Methoxy-Polyethylenglycol-Epoetin beta | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XD03 | Methylaminolevulinat | |||
http://fhir.de/CodeSystem/bfarm/atc | H02AB04 | Methylprednisolon | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX10 | Midostaurin | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AX15 | Mifamurtid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX09 | Miltefosin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CH01 | Mistelkraut | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CP01 | Mistelkraut | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AX01 | Mitobronitol | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX16 | Mitoguazon | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DC03 | Mitomycin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX23 | Mitotan | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DB07 | Mitoxantron | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AA03 | Molgramostim | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA02 | Muromonab-CD3 | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA06 | Mycophenolsäure | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA23 | Natalizumab | |||
http://fhir.de/CodeSystem/bfarm/atc | V03AF10 | Natriumlevofolinat | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BB07 | Nelarabin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EH02 | Neratinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EA03 | Nilotinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BB02 | Nilutamid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AD06 | Nimustin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX09 | Nintedanib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XK02 | Niraparib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC17 | Nivolumab | ~L01FF01(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01XC15 | Obinutuzumab | ~L01FA03(Reklassifizierung zu CD20-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01XX36 | Oblimersen | |||
http://fhir.de/CodeSystem/bfarm/atc | H01CB02 | Octreotid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XK01 | Olaparib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC27 | Olaratumab | ~L01FX10(Reklassifizierung zu andere monoklonale Antikörper) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01XX40 | Omacetaxinmepesuccinat | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AC02 | Oprelvekin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EB04 | Osimertinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XA03 | Oxaliplatin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CD01 | Paclitaxel | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CD03 | Paclitaxelpoliglumex | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EF01 | Palbociclib | |||
http://fhir.de/CodeSystem/bfarm/atc | V03AF08 | Palifermin | |||
http://fhir.de/CodeSystem/bfarm/atc | M05BA03 | Pamidronsäure | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC08 | Panitumumab | ~L01FE02(Reklassifizierung zu EGFR-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01XH03 | Panobinostat | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX03 | Pazopanib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX24 | Pegaspargase | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AA13 | Pegfilgrastim | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AB11 | Peginterferon alfa-2a | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AB10 | Peginterferon alfa-2b | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC18 | Pembrolizumab | ~L01FF02(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01BA04 | Pemetrexed | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX08 | Pentostatin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC13 | Pertuzumab | ~L01FD02(Reklassifizierung zu HER2-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01AX02 | Pipobroman | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DB08 | Pirarubicin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DB11 | Pixantron | |||
http://fhir.de/CodeSystem/bfarm/atc | V03AX10 | Placebo | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AX16 | Plerixafor | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DC02 | Plicamycin | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AX08 | Poly ICLC | |||
http://fhir.de/CodeSystem/bfarm/atc | L02AA02 | Polyestradiolphosphat | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XA05 | Polyplatillen | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AX06 | Pomalidomid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EA05 | Ponatinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XD01 | Porfimer natrium | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BA05 | Pralatrexat | |||
http://fhir.de/CodeSystem/bfarm/atc | D07AC18 | Prednicarbat | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AA08 | Prednimustin | |||
http://fhir.de/CodeSystem/bfarm/atc | H02AB06 | Prednisolon | |||
http://fhir.de/CodeSystem/bfarm/atc | H02AB07 | Prednison | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XB01 | Procarbazin | |||
http://fhir.de/CodeSystem/bfarm/atc | D05AD | Psoralene zur topischen Anwendung | |||
http://fhir.de/CodeSystem/bfarm/atc | D05BA | Psoralene zur systemischen Anwendung | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX11 | Quizartinib | |||
http://fhir.de/CodeSystem/bfarm/atc | G03XC01 | Raloxifen | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BA03 | Raltitrexed | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC21 | Ramucirumab | ~L01FG02(Reklassifizierung zu VEGF-/VEGFR-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01AD07 | Ranimustin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX05 | Regorafenib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EF02 | Ribociclib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AC04 | Rilonacept | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX19 | Ripretinib | |||
http://fhir.de/CodeSystem/bfarm/atc | M05BA07 | Risedronsäure | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC02 | Rituximab | ~L01FA01(Reklassifizierung zu CD20-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01XH02 | Romidepsin | |||
http://fhir.de/CodeSystem/bfarm/atc | B02BX04 | Romiplostim | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AB15 | Ropeginterferon alfa-2b | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XK03 | Rucaparib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EJ01 | Ruxolitinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XA04 | Satraplatin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX66 | Selinexor | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EE04 | Selumetinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AD03 | Semustin | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AC11 | Siltuximab | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AA10 | Sirolimus | |||
http://fhir.de/CodeSystem/bfarm/atc | H01CB01 | Somatostatin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XJ02 | Sonidegib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX02 | Sorafenib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AD04 | Streptozocin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX01 | Sunitinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AD02 | Tacrolimus | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX67 | Tagraxofusp | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XK04 | Talazoparib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX51 | Talimogen laherparepvec | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BA01 | Tamoxifen | |||
http://fhir.de/CodeSystem/bfarm/atc | L03AX11 | Tasonermin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC53 | Tegafur, Kombinationen | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC63 | Tegafur und Uracil | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC73 | Tegafur, Gimeracil und Oteracil | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XD05 | Temoporfin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AX03 | Temozolomid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EG01 | Temsirolimus | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CB02 | Teniposid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX21 | Tepotinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AX02 | Thalidomid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AC01 | Thiotepa | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX18 | Tiazofurin | |||
http://fhir.de/CodeSystem/bfarm/atc | M05BA05 | Tiludronsäure | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BB03 | Tioguanin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX71 | Tisagenlecleucel | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EK03 | Tivozanib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AC07 | Tocilizumab | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CE01 | Topotecan | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BA02 | Toremifen | |||
http://fhir.de/CodeSystem/bfarm/atc | V10XA53 | Tositumomab/(131I)Iodtositumomab | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CX01 | Trabectedin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EE01 | Trametinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XC03 | Trastuzumab | ~L01FD01(Reklassifizierung zu HER2-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01XC14 | Trastuzumab emtansin | ~L01FD03(Reklassifizierung zu HER2-Inhibitoren) | ||
http://fhir.de/CodeSystem/bfarm/atc | L01AB02 | Treosulfan | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XF01 | Tretinoin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AC02 | Triaziquon | |||
http://fhir.de/CodeSystem/bfarm/atc | L01BC59 | Trifluridin, Kombinationen | |||
http://fhir.de/CodeSystem/bfarm/atc | L02AE04 | Triptorelin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AA07 | Trofosfamid | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EH03 | Tucatinib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01AD08 | Uramustin | |||
http://fhir.de/CodeSystem/bfarm/atc | N03AG01 | Valproinsäure | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DB09 | Valrubicin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EX04 | Vandetanib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XK05 | Veliparib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EC01 | Vemurafenib | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX52 | Venetoclax | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CA01 | Vinblastin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CA02 | Vincristin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CA03 | Vindesin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CA05 | Vinflunin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01CA04 | Vinorelbin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XJ01 | Vismodegib | |||
http://fhir.de/CodeSystem/bfarm/atc | L04AD03 | Voclosporin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XH01 | Vorinostat | |||
http://fhir.de/CodeSystem/bfarm/atc | L02BG05 | Vorozol | |||
http://fhir.de/CodeSystem/bfarm/atc | L01XX53 | Vosaroxin | |||
http://fhir.de/CodeSystem/bfarm/atc | L01EL03 | Zanubrutinib | |||
http://fhir.de/CodeSystem/bfarm/atc | M05BA08 | Zoledronsäure | |||
http://fhir.de/CodeSystem/bfarm/atc | L01DB05 | Zorubicin |